Re-formulating Gehan’s design as a flexible two-stage single-arm trial

Abstract Background Gehan’s two-stage design was historically the design of choice for phase II oncology trials. One of the reasons it is less frequently used today is that it does not allow for a formal test of treatment efficacy, and therefore does not control conventional type-I and type-II error...

Full description

Bibliographic Details
Main Authors: Michael J. Grayling, Adrian P. Mander
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12874-019-0659-2